Difficulty: Medium
Average Score: 70%
Practice
What is the rationale for combining levodopa with carbidopa?
Correct answer
B
Rationale
Levodopa treats Parkinson's by crossing the blood-brain barrier and converting to dopamine, but peripheral metabolism by dopa decarboxylase reduces its availability and causes side effects like nausea. Carbidopa, a peripheral dopa decarboxylase inhibitor, doesn't cross into the CNS, so it prevents levodopa breakdown outside the brain, increasing its CNS entry and efficacy. It doesn't stimulate dopamine receptors├óÔé¼ÔÇØlevodopa's metabolite does that. Absorption isn't directly enhanced; bioavailability improves due to less peripheral loss. Peripheral dopamine production decreases with carbidopa, not increases, reducing side effects. COMT inhibition (e.g., entacapone) is a separate strategy. By blocking peripheral conversion, carbidopa ensures more levodopa reaches the brain, optimizing therapy and minimizing adverse effects.